GJA5 and cardiomyopathy: Furthermore, altered expression of Cx40 and Cx43 has been observed in mouse and human cardiomyopathies with aberrant ventricular conduction (Akar et al., 2004; Mueller et al., 2011; Sedmera et al., 2016; Tang et al., 2013).